These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30069972)

  • 41. SUMO-1 Gene Silencing Inhibits Proliferation and Promotes Apoptosis of Human Gastric Cancer SGC-7901 Cells.
    Jin L; Shen K; Chen T; Yu W; Zhang H
    Cell Physiol Biochem; 2017; 41(3):987-998. PubMed ID: 28222440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.
    Li H; Jiang X; Niu X
    Med Sci Monit; 2017 Feb; 23():919-928. PubMed ID: 28216611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway.
    Jiang W; Zhao S; Jiang X; Zhang E; Hu G; Hu B; Zheng P; Xiao J; Lu Z; Lu Y; Ni J; Chen C; Wang X; Yang L; Wan R
    Cancer Lett; 2016 Feb; 371(2):314-25. PubMed ID: 26683776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knockdown of FAM3B triggers cell apoptosis through p53-dependent pathway.
    Mou H; Li Z; Yao P; Zhuo S; Luan W; Deng B; Qian L; Yang M; Mei H; Le Y
    Int J Biochem Cell Biol; 2013 Mar; 45(3):684-91. PubMed ID: 23246487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
    Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Phospholipase C δ1 (PLCD1) inhibits the proliferation, invasion and migration of CAPAN-1 and BXPC-3 pancreatic cancer cells].
    Hu D; Jiang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):739-45. PubMed ID: 27371838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential role of Notch1 signaling pathway in laryngeal squamous cell carcinoma cell line Hep-2 involving proliferation inhibition, cell cycle arrest, cell apoptosis, and cell migration.
    Jiao J; Qin Z; Li S; Liu H; Lu Z
    Oncol Rep; 2009 Oct; 22(4):815-23. PubMed ID: 19724860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of microRNA-34a/SIRT1/p53 signal pathway on notoginsenoside R₁ delaying vascular endothelial cell senescence].
    Lai XH; Lei Y; Yang J; Xiu CK
    Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):577-584. PubMed ID: 29600625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DEPDC1B enhances malignant phenotypes of multiple myeloma through upregulating CCNB1 and inhibiting p53 signaling pathway.
    Fei H; Shi X; Li S; Li Y; Yin X; Wu Z; Wang W; Shi H; Li R
    Tissue Cell; 2024 Feb; 86():102263. PubMed ID: 37979396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory effect of ARHI on pancreatic cancer cells and NF-κB activity.
    Hu YQ; Si LJ; Ye ZS; Lin ZH; Zhou JP
    Mol Med Rep; 2013 Apr; 7(4):1180-4. PubMed ID: 23447002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
    Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M
    Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
    Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
    Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis.
    Liu QG; Li YJ; Yao L
    Pancreatology; 2018 Sep; 18(6):678-688. PubMed ID: 30055941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of ginsenoside Rg1 on the senescence of vascular smooth muscle cells.
    Li SG; Yan MZ; Zhang D; Ye M; Deng JJ
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin.
    Xu D; Wang Q; An Y; Xu L
    Mol Med Rep; 2013 Aug; 8(2):379-84. PubMed ID: 23732815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deoxyelephantopin impairs growth of cervical carcinoma SiHa cells and induces apoptosis by targeting multiple molecular signaling pathways.
    Farha AK; Dhanya SR; Mangalam SN; Geetha BS; Latha PG; Remani P
    Cell Biol Toxicol; 2014 Dec; 30(6):331-43. PubMed ID: 25260383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
    Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway.
    Cao X; Yao N; Zhao Z; Fu Y; Hu Y; Zhu P; Shi W; Tang L
    Bioengineered; 2022 Mar; 13(3):7771-7784. PubMed ID: 35286235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.